These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25233691)

  • 1. [Phenotypic detection of beta-lactamases production in Enterobacteriaceae].
    Cirković I; Pavlović L; Konstantinović N; Kostić K; Jovanović S; Djukić S
    Srp Arh Celok Lek; 2014; 142(7-8):457-63. PubMed ID: 25233691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of Vitek 2 performance for identifying extended spectrum beta-lactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp"].
    Diamante P; Camporese A
    Infez Med; 2006 Dec; 14(4):216-26. PubMed ID: 17380089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.
    Thomson KS; Sanders CC; Moland ES
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1393-400. PubMed ID: 10348759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Jean SS; Hsueh PR;
    J Antimicrob Chemother; 2017 Jan; 72(1):166-171. PubMed ID: 27703058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.
    Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of extended-spectrum beta-lactamases and drug sensitivity test in clinical isolates of the family Enterobacteriaceae in Shanghai].
    Lin Q; Luo W; Xiu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):420-2. PubMed ID: 11778509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
    Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
    Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing challenge of ESBLs.
    Perez F; Endimiani A; Hujer KM; Bonomo RA
    Curr Opin Pharmacol; 2007 Oct; 7(5):459-69. PubMed ID: 17875405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
    Ko SY; Chung JW; Song AJ; Yoon NS; Sung H; Kim MN
    Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extended-spectrum beta-lactamase detection in Enterobacteriaceae and antibiotic susceptibility analysis].
    Cao W; Tong MH; Wang JG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):77-8. PubMed ID: 12575246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current antimicrobial susceptibility testing for beta-lactamase-producing Enterobacteriaceae in clinical settings.
    Pereckaite L; Tatarunas V; Giedraitiene A
    J Microbiol Methods; 2018 Sep; 152():154-164. PubMed ID: 30063958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.